improvement of cell freezing technologies: towards a fully closed process

2
MEETING ABSTRACT Open Access Improvement of cell freezing technologies: towards a fully closed process Aurore Polès-Lahille * , Brigitte Lafuente, Virginie Perrier, David Balbuena, Didier Peyret From 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies Vienna, Austria. 15-18 May 2011 Cell culture from vials usually includes an open phase performed under laminar flow hoods. Even if disposable and small closed systems are available, at least the first cell culture step after vial thawing, which is a centrifuga- tion, is performed in disposable but open containers. This step is critical as the risk of contamination is high and it also has a direct impact on process timelines. In order to reduce the risk of contamination during thawing, Merck Serono Biodevelopment studied the pos- sibility of freezing cell banks in bags and to directly thaw- ing them directly in disposable and closed containers. The first step of this study was to evaluate if the DMSO present in freezing media had to be removed just after vial thawing or not. In general, this cryopro- tective organic solvent is removed by centrifugation to avoid any toxic effect on cells. So vials from two different mammalian cell lines were thawed, each with and without a centrifugation step to remove DMSO, or not. Afterwards the cell amplification was performed in the same way for the two different thaw- ing procedures. The population doubling level and the via- bility were monitored for more than 15 days and there was no significant impact neither on cell growth nor on viability whether DMSO was removed or not just after thawing, or not. The important parameter to take into account was the percentage of DMSO after dilution which had to be less than 0,5%. In order to reduce the risk of preparing cell banks, Merck Serono Biodevelopment looked at different disposable closed systems which allow cell banks to be prepared with- out laminar flow. It is possible to expand cells in closed containers such as spinners, shake flasks or rollers with deep tubes in addition to bags or disposable bioreactors. In order to concentrate cells or to change the medium from cell amplification to a cell freezing medium a centrifugation step may be necessary. Single use 500mL centrifuge tubes with deep tube and air vent are also available. In order to freeze cells, Merck Serono Biodevelopment evaluated sev- eral bags from several suppliers and chose the NovaSep- tum ® 100mL bag and the NovaSeptum ® Case. The combination of these 2 elements ensured the integrity of the bag during freezing at -80°C (Figure 1-2). Thus 50mL of two different concentrated mammalian cell suspensions were frozen at -80°C and thawed in dispo- sable and closed containers. The cells were not centrifuged just after thawing but expanded in order to seed a produc- tion bioreactor. The cells were also maintained in order to * Correspondence: [email protected] Merck Serono Biodevelopment, Martillac, France, 33650 Figure 1 NovaSeptum 100mL bag and NovaSeptum case configurations Polès-Lahille et al. BMC Proceedings 2011, 5(Suppl 8):P1 http://www.biomedcentral.com/1753-6561/5/S8/P1 © 2011 Polès-Lahille et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: aurore-poles-lahille

Post on 06-Jul-2016

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Improvement of cell freezing technologies: towards a fully closed process

MEETING ABSTRACT Open Access

Improvement of cell freezing technologies:towards a fully closed processAurore Polès-Lahille*, Brigitte Lafuente, Virginie Perrier, David Balbuena, Didier Peyret

From 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based TechnologiesVienna, Austria. 15-18 May 2011

Cell culture from vials usually includes an open phaseperformed under laminar flow hoods. Even if disposableand small closed systems are available, at least the firstcell culture step after vial thawing, which is a centrifuga-tion, is performed in disposable but open containers.This step is critical as the risk of contamination is highand it also has a direct impact on process timelines.

In order to reduce the risk of contamination duringthawing, Merck Serono Biodevelopment studied the pos-sibility of freezing cell banks in bags and to directly thaw-ing them directly in disposable and closed containers.

The first step of this study was to evaluate if theDMSO present in freezing media had to be removedjust after vial thawing or not. In general, this cryopro-tective organic solvent is removed by centrifugation toavoid any toxic effect on cells.

So vials from two different mammalian cell lines werethawed, each with and without a centrifugation step toremove DMSO, or not. Afterwards the cell amplificationwas performed in the same way for the two different thaw-ing procedures. The population doubling level and the via-bility were monitored for more than 15 days and therewas no significant impact neither on cell growth nor onviability whether DMSO was removed or not just afterthawing, or not. The important parameter to take intoaccount was the percentage of DMSO after dilution whichhad to be less than 0,5%.

In order to reduce the risk of preparing cell banks, MerckSerono Biodevelopment looked at different disposableclosed systems which allow cell banks to be prepared with-out laminar flow. It is possible to expand cells in closedcontainers such as spinners, shake flasks or rollers withdeep tubes in addition to bags or disposable bioreactors. Inorder to concentrate cells or to change the medium fromcell amplification to a cell freezing medium a centrifugation

step may be necessary. Single use 500mL centrifuge tubeswith deep tube and air vent are also available. In order tofreeze cells, Merck Serono Biodevelopment evaluated sev-eral bags from several suppliers and chose the NovaSep-tum® 100mL bag and the NovaSeptum® Case. Thecombination of these 2 elements ensured the integrity ofthe bag during freezing at -80°C (Figure 1-2).

Thus 50mL of two different concentrated mammaliancell suspensions were frozen at -80°C and thawed in dispo-sable and closed containers. The cells were not centrifugedjust after thawing but expanded in order to seed a produc-tion bioreactor. The cells were also maintained in order to

* Correspondence: [email protected] Serono Biodevelopment, Martillac, France, 33650

Figure 1 NovaSeptum 100mL bag and NovaSeptum caseconfigurations

Polès-Lahille et al. BMC Proceedings 2011, 5(Suppl 8):P1http://www.biomedcentral.com/1753-6561/5/S8/P1

© 2011 Polès-Lahille et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the CreativeCommons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited.

Page 2: Improvement of cell freezing technologies: towards a fully closed process

see if there was a long term impact of non-DMSO removalon viability and cell growth. The population doublinglevel, the cell viability obtained in disposable closed cellculture containers in addition to viable cell density, meta-bolism, molecule quantity and quality obtained in bioreac-tors were monitored. These parameters were compared tothe same process performed with cells coming from vials.

There was no process performance difference obtainedbetween cells frozen in bags and cells frozen in vials.Cell freezing in bags without DMSO removal allows afully closed cell culture and production process to beperformed. It also allows process timelines to bereduced by least 2 weeks.

The study will continue with a focus on bags whichare compatible with nitrogen containers. The qualityaspect will also be studied in order to be able to preparea full or part of manufacturing of cell banks in bags.

Published: 22 November 2011

doi:10.1186/1753-6561-5-S8-P1Cite this article as: Polès-Lahille et al.: Improvement of cell freezingtechnologies: towards a fully closed process. BMC Proceedings 2011 5(Suppl 8):P1.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

Figure 2 NovaSeptum 100mL bag and NovaSeptum caseconfigurations

Polès-Lahille et al. BMC Proceedings 2011, 5(Suppl 8):P1http://www.biomedcentral.com/1753-6561/5/S8/P1

Page 2 of 2